Company Summary

Keenova Therapeutics Public Limited Company was set up on Wednesday the 9th of January 2013. Their current partial address is Dublin 15, and the current official company status is Normal, however please note the RiskWatch entry below. The company has 9 directors who have also been the directors of 1 other Irish company between them. This Irish company shares its Eircode with at least 9 other companies.

Company Name:Keenova Therapeutics Public Limited Company
Company Status:NORMAL
COMPANY HAS EXITED EXAMINERSHIP
Date 18/11/2023
HIGH COURT APPOINTMENT
Date 22/09/2023
HIGH COURT APPOINTMENT
Date 28/02/2022
HIGH COURT PETITION
Presentation Date 14/02/2022
Company Address:College Business & Technology Park,
Cruiserath,
Blanchardstown, Dublin 15
Telephone:+353 (0)1 6960000
Website:www.mallinckrodt.com
Company Size:Log-In To View
Disclaimer Other Details
Please note the contact details displayed above are collected from a variety of public sources and are appended to this report for your convenience. As they are non-CRO data, we can not vouch for their accuracy or timeliness. To update contact details on this company simply email us.

Generate a B2B Marketing List with ease and grow your business. Identify key decision makers and pre-qualified new prospects for your sales and business development teams.

Similar Companies - Create a marketing list of similar companies

Latest Updates

The latest documents filed with the Companies Registration Office for Keenova Therapeutics Public Limited Company (which can include the Account Details) are listed below.

CRO DocumentEffective DateReceived By CROView Now
H5 - PURCHASING OWN SHARES30/09/202501/05/2026Join Up
Form B5 - Return of Allotments23/12/202501/05/2026Join Up
Form B7 - Notice of Consolidation, Division, Conversion30/09/202530/04/2026Join Up
Form B5 - Return of Allotments23/10/202530/04/2026Join Up
B5 - Details of the allottees23/10/202530/04/2026Join Up
THIS COMPANY HAS 470 OTHER DOCS »

View CRO company documents and company reports any Irish company or business with ease.

Credit Report

View the Latest Credit Report and Credit Limit on Keenova Therapeutics Public Limited Company.

Company Status:Normal
COMPANY HAS EXITED EXAMINERSHIP
Date 18/11/2023
HIGH COURT APPOINTMENT
Date 22/09/2023
HIGH COURT APPOINTMENT
Date 28/02/2022
HIGH COURT PETITION
Presentation Date 14/02/2022
Latest Credit Movement:
Date of Last Movement:17/07/2025
Latest Accounts Filed:08/07/2025
Report Based on Accounts:27/12/2024
Next Set of Accounts Due:30/09/2026
Overdue:No
Credit Score:Join-Up to View

Full Credit Rating

To View the latest Credit Rating or Credit Limit on Keenova Therapeutics Public Limited Company simply click 'Log-In' or 'Join-Up' below.

Vision-net Credit Scores save your business the time and cost of chasing slow payers. Evaluate risk at client application stage or run continuous credit checks on your full customer base.

Directors & Owners

Satisfy due diligence requirements on Keenova Therapeutics Public Limited Company in one single 'time-saving' search. Run full background checks for Fitness and Probity on the directors of Keenova Therapeutics Public Limited Company and Anti-Money Laundering checks (AML checks) on Keenova Therapeutics Public Limited Company

Directors details are available to logged in users.

Ownership Structure

Company Type:PLC - Public Limited Company

Compliance

Log-in now to run Due Diligence checks and Compliance checks on Keenova Therapeutics Public Limited Company or click Join-up to get started.

Background check Companies, Sole Traders or Individuals and minimise your spend with more efficient Anti-Money Laundering checks and reports.

Ask Us A Question...?

Risk Audit: Clearer Insight Across Your Portfolio

01/05/2026

In today’s trading environment, risk rarely presents itself in a single moment. Credit profiles shift, financial resilience weakens, and company status changes can occur quietly in the background.

Read More »

ESG Insight for Smarter Business Decisions

27/04/2026

As we recently marked Earth Day 2026, the focus on sustainability has highlighted a simple reality: ESG is now a practical part of everyday business decision-making.

Read More »

Q1 Insights: Shifts in Leadership and Credit Dynamics

17/04/2026

While strong new business formation set a positive tone for the opening quarter of 2026, the wider financial and governance picture reveals a more nuanced environment.

Read More »

Irish Start-ups Jump 14% Despite Economic Pressures

08/04/2026

The first quarter of 2026 offers a clear view of how Irish entrepreneurs are responding to a challenging economic environment.

Read More »